To hear about similar clinical trials, please enter your email below
Trial Title:
Tumors of the Peripheral Nervous System
NCT ID:
NCT05735548
Condition:
Tumor of Peripheral Nerve
Conditions: Official terms:
Peripheral Nervous System Neoplasms
Conditions: Keywords:
outcome, neurosurgery
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Summary:
The goal of this observational study is to individuate tumors' and patients' features
influencing the outcome after surgical tumor removal.
Detailed description:
Patients operated because of removal of Peripheral Nervous System (PNS) tumor will be
recruited accordingly to the inclusion criteria: the aims of the study will be
illustrated and the informed consent signed.
All the clinical and neuroradiological perioperative documents of the enrolled patients
will be analyzed. As follow-up, thorough neurological exam wil be performed and specific
surveys about after surgery social and working life will be administered;
neuroradiological imaging will be performed.
Then, the results will be investigated to individuate which factors were related to the
outcome.
Criteria for eligibility:
Study pop:
Patients with confirmed histology of peripheral nerve tumor, operated at our hospital
during the 10 years before the study started.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- ≥ 18 y.o.
- neurosurgical removal of peripheral nerve tumor at our University Hospital
"Fondazione Policlinico Universitario Agostino Gemelli (FPG)" during the previous 10
years
- signed consent to study participation
Exclusion Criteria:
- < 18 y.o.
- neurosurgical treatment because other causes (chronic entrapment syndromes, acute
nerve lesion)
- denied consent to study participation
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Address:
City:
Rome
Zip:
00168
Country:
Italy
Start date:
July 1, 2021
Completion date:
June 30, 2024
Lead sponsor:
Agency:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class:
Other
Source:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05735548
